BVXV
NASDAQ

BiondVax Pharmaceuticals Ltd ADR

Overview
BVXV
Symbol
NASDAQ
Exchange
About stock

BiondVax Pharmaceuticals Ltd., a development stage biopharmaceutical company, focuses on developing, manufacturing, and commercializing products for the prevention and treatment of infectious diseases and other illnesses in Israel. The company has licensing and collaboration agreement with Max Planck Society and University Medical Center Göttingen for the development and commercialization of COVID-19 nanosized antibody (NanoAb); and development and commercialization of NanoAbs for various other disease indications. The company was incorporated in 2003 and is headquartered in Jerusalem, Israel.

Address: Jerusalem BioPark Building, Jerusalem, Israel

BiondVax Pharmaceuticals Ltd ADR dividend calculator
Report issue